Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion type Assertion NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_head.
- NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_provenance.
- NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion evidence source_evidence_literature NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_provenance.
- NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion SIO_000772 21677662 NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_provenance.
- NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion wasDerivedFrom befree-20140225 NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_provenance.
- NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion wasGeneratedBy ECO_0000203 NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_provenance.